Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 31 announcements

Share price: ₹1,520.20
Market cap: ₹2,172 Cr
Revenue (annual): ₹635.5 Cr
Net profit (annual): ₹32.62 Cr
P/E (TTM): 49.6×Sector 47.4×
Promoter holding: 44.57%+0.40% QoQ
FII holding: 1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 5 Financial Results 4 Earnings Call 3 Results Update 2 Other Announcement 2 Bonus Issue 2 Annual General Meeting 2 Acquisition 2 Product Launch 1 Dividend 1 Debt & Borrowing 1 Capacity Expansion 1 Business Update 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Jun 2026 17:54 IST BSE

Annual General Meeting

Fredun Pharmaceuticals Annual General Meeting

Fredun Pharmaceuticals held its 39th Annual General Meeting on June 30, 2026. The meeting covered ordinary and special resolutions, including dividend declarations.

Read the filing ↗

8 Jun 2026 19:32 IST BSE

Annual General Meeting

Fredun Pharmaceuticals Annual General Meeting

Fredun Pharmaceuticals scheduled its 39th AGM for June 30, 2026. The share transfer books will remain closed from June 24 to June 30 for meeting purposes.

Read the filing ↗